Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension

被引:2
|
作者
Park, Lidia [1 ]
Donohue, Lee [2 ]
Lakshminrusimha, Satyan [2 ]
Sankaran, Deepika [2 ]
机构
[1] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Dept Pediat, Div Neonatol, Sacramento, CA 95817 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; PATHOGENESIS;
D O I
10.1038/s41372-022-01489-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:236 / 237
页数:2
相关论文
共 50 条
  • [31] Electroretinographic Responses in Retinopathy of Prematurity Treated Using Intravitreal Bevacizumab or Laser
    Curran, Amber-Lee K.
    Stukin, Justyna
    Ambrosio, Lucia
    Mantagos, Iason S.
    Wu, Carolyn
    Vanderveen, Deborah K.
    Hansen, Ronald M.
    Akula, James D.
    Fulton, Anne B.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 252 : 275 - 285
  • [32] Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy
    Mintz-Hittner, Helen A.
    Geloneck, Megan M.
    Chuang, Alice Z.
    OPHTHALMOLOGY, 2016, 123 (09) : 1845 - 1855
  • [33] The Effect of Intravitreal Bevacizumab Dose on Retinal Vascular Progression in Retinopathy of Prematurity
    Bayramoglu, Sadik Etka
    Sayin, Nihat
    OPHTHALMOLOGICA, 2022, 245 (02) : 161 - 172
  • [34] Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment
    Chang, Yu-Shan
    Chen, Ying-Tin
    Lai, Tso-Ting
    Chou, Hung-Chieh
    Chen, Chien-Yi
    Hsieh, Wu-Shiun
    Yang, Chung-May
    Yeh, Po-Ting
    Tsao, Po-Nien
    PLOS ONE, 2019, 14 (10):
  • [35] Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection
    Xu, Yu
    Zhang, Qi
    Kang, Xiaoli
    Zhu, Ying
    Li, Jiakai
    Chen, Yiye
    Zhao, Peiquan
    ACTA OPHTHALMOLOGICA, 2013, 91 (04) : E304 - E310
  • [36] Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity
    Araz-Ersan, Bilge
    Kir, Nur
    Tuncer, Samuray
    Aydinoglu-Candan, Ozlem
    Yildiz-Inec, Dilbade
    Akdogan, Basri
    Ekici, Baris
    Demirel, Atalay
    Ozmen, Meral
    CURRENT EYE RESEARCH, 2015, 40 (06) : 585 - 591
  • [37] Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model
    Akkoyun, Imren
    Karabay, Gulten
    Haberal, Nihan
    Dagdeviren, Attila
    Yilmaz, Gursel
    Oto, Sibel
    Erkanli, Leyla
    Akova, Yonca A.
    ACTA OPHTHALMOLOGICA, 2012, 90 (06) : 564 - 570
  • [38] Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity
    Lee, B. J.
    Kim, J. H.
    Heo, H.
    Yu, Y. S.
    EYE, 2012, 26 (07) : 903 - 910
  • [39] A new, theoretically safer method of intravitreal injection of bevacizumab in progressive retinopathy of prematurity using scleral trans-illumination
    Patel, C. K.
    Walker, N. J.
    Kam, J. K.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (08) : 1107 - 1109
  • [40] Bevacizumab for retinopathy of prematurity and neurodevelopment
    Binenbaum, Gil
    JOURNAL OF AAPOS, 2023, 27 (01): : E1 - E2